|
|
|
Volumn 19, Issue SUPPL.D, 1998, Pages
|
|
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
LAMIFIBAN;
TIROFIBAN;
UNCLASSIFIED DRUG;
ACUTE HEART INFARCTION;
ATHERECTOMY;
BLEEDING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY DILATATION;
DRUG EFFICACY;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REVASCULARIZATION;
HEART PROTECTION;
HUMAN;
META ANALYSIS;
MORTALITY;
PRIORITY JOURNAL;
STENT;
UNSTABLE ANGINA PECTORIS;
ACETATES;
ANGINA, UNSTABLE;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
ATHERECTOMY, CORONARY;
CORONARY DISEASE;
FIBRINOLYTIC AGENTS;
HEPARIN;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
PEPTIDES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
TYROSINE;
|
|
EID: 0031939116
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (48)
|
|
References (40)
|
